Q1 2016 13F Holders as of 31 Mar 2016
-
Type / Class
-
Equity / Common Stock
-
Shares outstanding
-
80,437,135
-
Number of holders
-
112
-
Total 13F shares, excl. options
-
29,052,236
-
Shares change
-
-7,002,102
-
Total reported value, excl. options
-
$187,275,624
-
Value change
-
-$209,529,061
-
Put/Call ratio
-
47.9%
-
Number of buys
-
64
-
Number of sells
-
-77
-
Price
-
$6.44
Significant Holders of PTC THERAPEUTICS, INC. - Common Stock (PTCT) as of Q1 2016
176 filings reported holding PTCT - PTC THERAPEUTICS, INC. - Common Stock as of Q1 2016.
PTC THERAPEUTICS, INC. - Common Stock (PTCT) has 112 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 29,052,236 shares
of 80,437,135 outstanding shares and own 36.12% of the company stock.
Largest 10 shareholders include WELLINGTON MANAGEMENT GROUP LLP (4,699,733 shares), Sectoral Asset Management Inc (2,615,241 shares), VANGUARD GROUP INC (2,060,160 shares), TOCQUEVILLE ASSET MANAGEMENT L.P. (1,487,998 shares), BlackRock Fund Advisors (1,241,219 shares), BB BIOTECH AG (1,182,912 shares), FMR LLC (1,136,436 shares), FRONTIER CAPITAL MANAGEMENT CO LLC (967,367 shares), RENAISSANCE TECHNOLOGIES LLC (948,700 shares), and Camber Capital Management LLC (893,900 shares).
This table shows the top 112 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.